750 related articles for article (PubMed ID: 32746922)
21. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
Copaescu A; Smibert O; Gibson A; Phillips EJ; Trubiano JA
J Allergy Clin Immunol; 2020 Sep; 146(3):518-534.e1. PubMed ID: 32896310
[TBL] [Abstract][Full Text] [Related]
22. Covid-19: Perspectives on Innate Immune Evasion.
Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
Front Immunol; 2020; 11():580641. PubMed ID: 33101306
[TBL] [Abstract][Full Text] [Related]
23. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
24. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
25. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
Bellinvia S; Edwards CJ; Schisano M; Banfi P; Fallico M; Murabito P
Inflamm Res; 2020 Aug; 69(8):757-763. PubMed ID: 32468151
[TBL] [Abstract][Full Text] [Related]
26. [Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].
Liao J; Wen B; Deng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Oct; 36(10):941-947. PubMed ID: 33148390
[TBL] [Abstract][Full Text] [Related]
27. The COVID-19 pandemic.
Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
[TBL] [Abstract][Full Text] [Related]
28. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
Bindoli S; Felicetti M; Sfriso P; Doria A
Exp Biol Med (Maywood); 2020 Jun; 245(11):970-976. PubMed ID: 32460624
[TBL] [Abstract][Full Text] [Related]
29. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
Wang J; Jiang M; Chen X; Montaner LJ
J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
[TBL] [Abstract][Full Text] [Related]
30. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S
Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043
[TBL] [Abstract][Full Text] [Related]
31. Cytokine storm induced by SARS-CoV-2.
Song P; Li W; Xie J; Hou Y; You C
Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19.
Rao V; Thakur S; Rao J; Arakeri G; Brennan PA; Jadhav S; Sayeed MS; Rao G
Med Hypotheses; 2020 Oct; 143():109845. PubMed ID: 32425307
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection-induced immune responses: Friends or foes?
Li K; Hao Z; Zhao X; Du J; Zhou Y
Scand J Immunol; 2020 Aug; 92(2):e12895. PubMed ID: 32445403
[TBL] [Abstract][Full Text] [Related]
34. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
[TBL] [Abstract][Full Text] [Related]
35. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.
Song TZ; Zheng HY; Han JB; Jin L; Yang X; Liu FL; Luo RH; Tian RR; Cai HR; Feng XL; Liu C; Li MH; Zheng YT
Zool Res; 2020 Sep; 41(5):503-516. PubMed ID: 32772513
[TBL] [Abstract][Full Text] [Related]
36. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.
Hou X; Zhang X; Wu X; Lu M; Wang D; Xu M; Wang H; Liang T; Dai J; Duan H; Xu Y; Yu X; Li Y
Mol Cell Proteomics; 2020 Nov; 19(11):1749-1759. PubMed ID: 32788344
[TBL] [Abstract][Full Text] [Related]
37. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Ong CWM; Migliori GB; Raviglione M; MacGregor-Skinner G; Sotgiu G; Alffenaar JW; Tiberi S; Adlhoch C; Alonzi T; Archuleta S; Brusin S; Cambau E; Capobianchi MR; Castilletti C; Centis R; Cirillo DM; D'Ambrosio L; Delogu G; Esposito SMR; Figueroa J; Friedland JS; Ho BCH; Ippolito G; Jankovic M; Kim HY; Rosales Klintz S; Ködmön C; Lalle E; Leo YS; Leung CC; Märtson AG; Melazzini MG; Najafi Fard S; Penttinen P; Petrone L; Petruccioli E; Pontali E; Saderi L; Santin M; Spanevello A; van Crevel R; van der Werf MJ; Visca D; Viveiros M; Zellweger JP; Zumla A; Goletti D
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32586885
[TBL] [Abstract][Full Text] [Related]
38. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
[TBL] [Abstract][Full Text] [Related]
39. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
Rasmussen C; Niculescu I; Patel S; Krishnan A
AJNR Am J Neuroradiol; 2020 Sep; 41(9):1625-1628. PubMed ID: 32732269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
